Last updated: April 30, 2024
Sponsor: Shi Yun
Overall Status: Active - Not Recruiting
Phase
1
Condition
N/ATreatment
coenzyme Q10
Jiajian Guishen granules
Clinical Study ID
NCT06089395
JJGS on POR
Ages 20-45 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Woman who meet the diagnostic criteria for poor ovarian response;
- Woman who meet the TCM diagnostic criteria for kidney deficiency;
- Woman whose serum basal FSH(two consecutive menstrual cycles)between 10-25mIU/mL
- Woman whose AMH <1.1ng/ml;
- Woman aged ranged from 20-45 years old
- Woman whose body mass index (BMI)<35 kg/m2
- Womanwho voluntarily signed the informed consent form.
Exclusion
Exclusion Criteria:
- Woman who have combination of serious diseases such as cardiovascular,cerebrovascular, hepatic, renal and hematopoietic systems, and malignant tumors;
- Woman who have other endocrine diseases, such as polycystic ovary syndrome andhyperprolactinemia;
- Woman who are unable to cooperate with the treatment and follow-up, such as combinedneurological and psychiatric disorders, or those who are unwilling to cooperate.
- Woman who have used the same efficacy of herbs or other therapies in the last 1 month;
- Woman who are allergic to the drugs used in this study.
Study Design
Total Participants: 76
Treatment Group(s): 2
Primary Treatment: coenzyme Q10
Phase: 1
Study Start date:
June 01, 2024
Estimated Completion Date:
August 31, 2025
Study Description
Connect with a study center
Dongzhimen Hospital of Beijing University of Chinese Medicine
Beijing, Beijing 100700
ChinaSite Not Available
Xiyuan Hospital, China Academy of Traditional Chinese Medicine
Beijing, Beijing 100700
ChinaSite Not Available
Chaoyang Hospital Affiliated to Capital Medical University
Beijing,
ChinaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.